news
Global antimicrobial resistance fund to support development of innovative antibiotics
The fund has already raised $1 billion to support clinical research of novel antibiotics and intends to bring up to four new antibiotics to market by 2030.
List view / Grid view
ABPI (Association of the British Pharmaceutical Industry)
news
UK leads Europe in early clinical research, says new report
According to a new report, the UK is leading the rest of Europe for early-stage clinical research into new medicines and vaccines, with more than 600 commercial clinical trials taking place in the NHS.
news
New initiative launched to boost Northern Ireland’s life science industry
The UK’s newest life sciences asset, Health Innovation Research Alliance Northern Ireland (HIRANI), has been launched at a BIO reception.
news
Haseeb Ahmad has been named as the new president of ABPI
Haseeb Ahmad from Novartis Pharmaceuticals has been confirmed as the new president of the The Association of the British Pharmaceutical Industry (ABPI).
news
No-deal Brexit could mean temporary medicines export ban
The Association of the British Pharmaceutical Industry has called for a temporary ban on drugs exports in the event of a no-deal Brexit to prevent the NHS being hit by shortages...
news
Pharma industry ‘call for action’ following Brexit vote
The pharma industry has called for the government to act to ensure that patients receive their medications in the case of a ‘no deal’ situation...
news
Patients must get the medicine they need after Brexit
Patients could find that supplies of their medicines will be disrupted when the UK leaves the EU, according to a new briefing published by the Brexit Health Alliance...
news
Clinical trial transparency reaches record level
Disclosure rate of industry-sponsored clinical trials at 12 months has significantly improved year on year from 71% in 2009 to 93% in 2014, according to ABPI-sponsored study.
news
Joint policy document shows the potential impact of Brexit
The associations representing the European and British life science industry have launched a joint policy document on the potential impact of the United Kingdom’s exit from the European Union...
news
Budget 2017: Reaction from the UK’s pharmaceutical industry
The Chief Executive of the Association of the British Pharmaceutical Industry (ABPI), Mike Thompson responds to the UK’s Budget announcement...
news
Bluebird bio joins the ABPI as a full member
The Association of the British Pharmaceutical Industry (ABPI) has admitted the American biotech bluebird bio, Inc. as a full member...
article
SynBio: unlocking the commercial potential of a new bioscience industry
An exclusive column from the ABPI's Magda Papadaki about the implications of synthetic biology for the pharmaceutical industry...
news
UK trails behind EU in cancer diagnosis & treatment
A new report shows that the UK is trailing behind the rest of Europe in the diagnosis and treatment of cancer.
news
ABPI respond to statement of UK Government’s medicines regulation plans
The ABPI has responded to a joint letter from Jeremy Hunt, Secretary of State for Health, and Greg Clark, Secretary of State for Business, published by the Financial Times, that outlined the UK Government’s plans for the regulation of medicines as the UK leaves the European Union (EU).
news
Collaboration is ‘game changer’ in delivering cell and gene therapies
Collaboration between the pharmaceutical industry, patients and health regulators will be a ‘game changer’ in delivering exciting new cell and gene therapies to treat conditions like cancer and vision loss.
